UK markets closed

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
109.67+0.50 (+0.46%)
At close: 12:57PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5249.76B
Enterprise value 3246.49B
Trailing P/E 36.26
Forward P/E 133.00
PEG ratio (5-yr expected) 13.17
Price/sales (ttm)12.45
Price/book (mrq)25.02
Enterprise value/revenue 31.83
Enterprise value/EBITDA 73.90

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 364.55%
S&P500 52-week change 326.87%
52-week high 3118.68
52-week low 364.72
50-day moving average 3105.74
200-day moving average 388.65

Share statistics

Avg vol (3-month) 315.5k
Avg vol (10-day) 32.29k
Shares outstanding 51.74B
Implied shares outstanding 62.28B
Float 81.63B
% held by insiders 16.90%
% held by institutions 135.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.48
Forward annual dividend yield 41.35%
Trailing annual dividend rate 39.35
Trailing annual dividend yield 38.56%
5-year average dividend yield 42.08
Payout ratio 446.77%
Dividend date 326 Mar 2018
Ex-dividend date 415 Aug 2021
Last split factor 25:1
Last split date 301 Jan 2014

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 34.31%
Operating margin (ttm)42.00%

Management effectiveness

Return on assets (ttm)22.50%
Return on equity (ttm)73.49%

Income statement

Revenue (ttm)134.6B
Revenue per share (ttm)58.39
Quarterly revenue growth (yoy)15.20%
Gross profit (ttm)106.01B
EBITDA 60.42B
Net income avi to common (ttm)46.18B
Diluted EPS (ttm)3.01
Quarterly earnings growth (yoy)17.70%

Balance sheet

Total cash (mrq)35.39B
Total cash per share (mrq)15.44
Total debt (mrq)13.75B
Total debt/equity (mrq)20.80
Current ratio (mrq)1.03
Book value per share (mrq)28.85

Cash flow statement

Operating cash flow (ttm)58.19B
Levered free cash flow (ttm)32.65B